191 related articles for article (PubMed ID: 32857923)
1. Reduced liver cancer mortality with regular clinic follow-up among patients with chronic hepatitis B: A nationwide cohort study.
Shim JJ; Kim GA; Oh CH; Kim JW; Myung J; Kim BH; Oh IH
Cancer Med; 2020 Oct; 9(20):7781-7791. PubMed ID: 32857923
[TBL] [Abstract][Full Text] [Related]
2. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting.
Wong CR; Garcia RT; Trinh HN; Lam KD; Ha NB; Nguyen HA; Nguyen KK; Levitt BS; Nguyen MH
Dig Dis Sci; 2009 Dec; 54(12):2712-21. PubMed ID: 19876735
[TBL] [Abstract][Full Text] [Related]
3. Association of adjuvant antiviral therapy with risk of cancer progression and deaths in patients with hepatitis-B-virus-related hepatocellular carcinoma following curative treatment: a nationwide cohort study.
Yeh YC; Liu CJ; Kuo RN; Lai CL; Shau WY; Chen PJ; Lai MS
PLoS One; 2014; 9(7):e102051. PubMed ID: 25025231
[TBL] [Abstract][Full Text] [Related]
4. Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort Study.
Choi J; Kim HJ; Lee J; Cho S; Ko MJ; Lim YS
JAMA Oncol; 2019 Jan; 5(1):30-36. PubMed ID: 30267080
[TBL] [Abstract][Full Text] [Related]
5. Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population.
Papatheodoridis GV; Sypsa V; Dalekos G; Yurdaydin C; van Boemmel F; Buti M; Goulis J; Calleja JL; Chi H; Manolakopoulos S; Loglio A; Siakavellas S; Gatselis N; Keskın O; Lehretz M; Savvidou S; de la Revilla J; Hansen BE; Kourikou A; Vlachogiannakos I; Galanis K; Idilman R; Colombo M; Esteban R; Janssen HLA; Berg T; Lampertico P
J Hepatol; 2018 Jun; 68(6):1129-1136. PubMed ID: 29427727
[TBL] [Abstract][Full Text] [Related]
6. Association of Metabolic Risk Factors With Risks of Cancer and All-Cause Mortality in Patients With Chronic Hepatitis B.
Lee YB; Moon H; Lee JH; Cho EJ; Yu SJ; Kim YJ; Zoulim F; Lee J; Yoon JH
Hepatology; 2021 Jun; 73(6):2266-2277. PubMed ID: 33140415
[TBL] [Abstract][Full Text] [Related]
7. Diabetes poses a higher risk of hepatocellular carcinoma and mortality in patients with chronic hepatitis B: A population-based cohort study.
Shyu YC; Huang TS; Chien CH; Yeh CT; Lin CL; Chien RN
J Viral Hepat; 2019 Jun; 26(6):718-726. PubMed ID: 30739359
[TBL] [Abstract][Full Text] [Related]
8. Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response.
Kim GA; Han S; Kim HD; An J; Lim YS
J Viral Hepat; 2017 Nov; 24(11):990-997. PubMed ID: 28499070
[TBL] [Abstract][Full Text] [Related]
9. High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B.
Kim GA; Lim YS; Han S; Choi J; Shim JH; Kim KM; Lee HC; Lee YS
Gut; 2018 May; 67(5):945-952. PubMed ID: 29055908
[TBL] [Abstract][Full Text] [Related]
10. Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B.
Park Y; Kang D; Sinn DH; Kim H; Hong YS; Cho J; Gwak GY
World J Gastroenterol; 2023 Jun; 29(24):3843-3854. PubMed ID: 37426323
[TBL] [Abstract][Full Text] [Related]
11. Comparison of overall survival between antiviral-induced viral suppression and inactive phase chronic hepatitis B patients.
Cho YY; Lee JH; Chang Y; Nam JY; Cho H; Lee DH; Cho EJ; Lee DH; Yu SJ; Lee JM; Kim YJ; Yoon JH
J Viral Hepat; 2018 Oct; 25(10):1161-1171. PubMed ID: 29741286
[TBL] [Abstract][Full Text] [Related]
12. Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease.
Cho JY; Paik YH; Sohn W; Cho HC; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Gut; 2014 Dec; 63(12):1943-50. PubMed ID: 24615378
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study.
Huang YW; Wang TC; Lin SC; Chang HY; Chen DS; Hu JT; Yang SS; Kao JH
Clin Infect Dis; 2013 Dec; 57(12):1695-702. PubMed ID: 24051864
[TBL] [Abstract][Full Text] [Related]
14. Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study.
Tran S; Jeong D; Henry L; Cheung RC; Nguyen MH
Am J Gastroenterol; 2021 Sep; 116(9):1885-1895. PubMed ID: 33927125
[TBL] [Abstract][Full Text] [Related]
15. Effect of Statin Use on Liver Cancer Mortality Considering Hypercholesterolemia and Obesity in Patients with Non-Cirrhotic Chronic Hepatitis B.
Kim GA; Shim JJ; Lee JS; Kim BH; Kim JW; Oh CH; Oh CM; Oh IH; Park SY
Yonsei Med J; 2019 Dec; 60(12):1203-1208. PubMed ID: 31769252
[TBL] [Abstract][Full Text] [Related]
16. Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B.
Lee J; Yoo SH; Sohn W; Kim HW; Choi YS; Won JH; Heo JY; Park SJ; Park YM
Clin Mol Hepatol; 2016 Sep; 22(3):339-349. PubMed ID: 27729627
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection.
Chayanupatkul M; Omino R; Mittal S; Kramer JR; Richardson P; Thrift AP; El-Serag HB; Kanwal F
J Hepatol; 2017 Feb; 66(2):355-362. PubMed ID: 27693539
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of patients with chronic hepatitis B in France (2008-2013): A nationwide, observational and hospital-based study.
Mallet V; Hamed K; Schwarzinger M
J Hepatol; 2017 Mar; 66(3):514-520. PubMed ID: 27826056
[TBL] [Abstract][Full Text] [Related]
19. High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation.
Choi GH; Kim GA; Choi J; Han S; Lim YS
Aliment Pharmacol Ther; 2019 Jul; 50(2):215-226. PubMed ID: 31135074
[TBL] [Abstract][Full Text] [Related]
20. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
